Cargando…

Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme

Background: Glioblastoma multiforme (GBM) is the most aggressive primary nervous system brain tumor. There is still a lack of effective methods to control its progression and recurrence in clinical treatment. It is clinically found that Xiaoliu Decoction (XLD) has the effect of treating brain tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ji, Li, Xue-Yu, Liang, Jing, Fang, Da-Lang, Yang, Zhao-Jian, Wei, Jie, Chen, Zhi-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420933/ https://www.ncbi.nlm.nih.gov/pubmed/36046228 http://dx.doi.org/10.3389/fgene.2022.940462

Ejemplares similares

A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma
por: Fan, Tianyu, et al.
Publicado: (2023)

Network pharmacological analysis of active components of Tongqiao Huoxue Decoction in the treatment of intracerebral hemorrhage
por: Wu, Ji, et al.
Publicado: (2022)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Regulatory pattern of abnormal promoter CpG island methylation in the glioblastoma multiforme classification
por: Wang, Rendong, et al.
Publicado: (2022)

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021)

Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Molecular mechanisms of the Guizhi decoction on osteoarthritis based on an integrated network pharmacology and RNA sequencing approach with experimental validation
por: Chen, Yan, et al.
Publicado: (2023)

In Vitro and In Vivo Inhibitory Effect of Gujin Xiaoliu Tang in Non-Small Cell Lung Cancer
por: Hou, Chao, et al.
Publicado: (2018)

IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
por: Kalya, Manasa, et al.
Publicado: (2021)

Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme
por: Yang, Yuling, et al.
Publicado: (2023)

Network pharmacology -based study on the mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme
por: Liang, Chen, et al.
Publicado: (2023)

Network pharmacological systems study of Huang-Lian-Tang in the treatment of glioblastoma multiforme
por: Liu, Wangrui, et al.
Publicado: (2021)

Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme
por: Sun, Ruohan, et al.
Publicado: (2021)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme
por: Wu, Gang, et al.
Publicado: (2022)

A genetic survival network for glioblastoma multiforme
por: Lin, Andy, et al.
Publicado: (2011)

Xiaoliu Pingyi Pecipe Inhibits Lung Pre-Metastatic Niche Formation and Prevents Myeloid-Derived Suppressor Cells Recruitment
por: Li, Honglin, et al.
Publicado: (2023)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Uncovering the Pharmacology of Xiaochaihu Decoction in the Treatment of Acute Pancreatitis Based on the Network Pharmacology
por: Zhan, Lianghui, et al.
Publicado: (2021)

Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
por: Ouyang, Jia-Ying, et al.
Publicado: (2023)

A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy
por: Zhao, Rongchuan, et al.
Publicado: (2021)

Network Pharmacology and Inflammatory Microenvironment Strategy Approach to Finding the Potential Target of Siraitia grosvenorii (Luo Han Guo) for Glioblastoma
por: Li, Juan, et al.
Publicado: (2021)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme
por: Huang, Runzhi, et al.
Publicado: (2020)

Glioblastoma multiforme restructures the topological connectivity of cerebrovascular networks
por: Hahn, Artur, et al.
Publicado: (2019)

Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome
por: Pooladi, Mehdi, et al.
Publicado: (2014)

Primitive Neuroectodermal Tumor with Glioblastoma Multiforme Components in an Adult: A Collision Tumor
por: Forbes, Victoria, et al.
Publicado: (2016)

Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin–Angiotensin System
por: Bradshaw, Amy Ruth, et al.
Publicado: (2016)

Study on complications of osteoporosis based on network pharmacology
por: Song, Zhijing, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2ejuphsi0jkh1bfhl4f0scuoec